Osicent 80 Mg (Osimertinib) – 30 Tablets
Osicent 80 mg is a kinase inhibitor used to treat metastatic EGFR T790M mutation-positive non-small cell lung cancer in patients who have progressed on previous EGFR tyrosine kinase inhibitors.
- The description claims that the mutation must be confirmed by an FDA-approved test.
AI Readiness
Good foundation, but some important product data is still missing.
72%